Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)
Pancragen: Research & Evidence
Early-Stage ResearchPublished research, clinical trial data, and evidence grading for Pancragen across studied indications.
Back to Pancragen overviewResearch Summary
Pancragen has zero PubMed-indexed human studies, zero RCTs, and no Western clinical trials. All efficacy claims derive from Russian-language animal studies that have not been independently replicated. FDA-approved diabetes medications including metformin, insulin, and GLP-1 receptor agonists have extensive human evidence.
Evidence by Indication (2 indications)
| Indication | Tier | Trials | Summary |
|---|---|---|---|
| Pancreatic function | Tier D | 0 | No human trials exist; rodent studies report improved pancreatic function but remain unverified |
| Metabolic regulation | Tier D | 0 | Animal data suggests glucose normalization effects but no human translation has been attempted |
Graded using our evidence tier methodology.